MetLife Investment Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $799K | Buy |
|
|||||
|
2022
Q4 | $325K | Hold |
|
|||||
|
2022
Q3 | $139K | Buy |
|
|||||
|
2022
Q2 | $35.6K | Sell |
|
|||||
|
2022
Q1 | $237K | Buy |
|
|||||
|
2021
Q4 | $41.7K | Sell |
|
|||||
|
2021
Q3 | $132K | Buy |
|
|||||
|
2021
Q2 | $68.3K | Sell |
|
|||||
|
2021
Q1 | $227K | Buy |
|
|||||
|
2020
Q4 | $332K | Hold |
|
|||||
|
2020
Q3 | $252K | Hold |
|
|||||
|
2020
Q2 | $277K | Buy |
|